Clean Yield Group Eli Lilly & CO Transaction History

Clean Yield Group

$296 Million
Q3 2024

A detailed history of Clean Yield Group transactions in Eli Lilly & CO stock. As of the latest transaction made, Clean Yield Group holds 3,619 shares of LLY stock, worth $2.85 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

3,619

Previous 3,637 0.49%

Holding current value

$2.85 Million

Previous $3.29 Million 2.61%

% of portfolio

1.08%

Previous 1.3%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$772.14 - $960.02 $13,898 - $17,280	-18 Reduced 0.49%	3,619 $3.21 Million
Q2 2024 Jul 10, 2024	BUY	$724.87 - $909.04 $2,899 - $3,636	4 Added 0.11%	3,637 $3.29 Million
Q1 2024 May 29, 2024	SELL	$592.2 - $792.28 $65,142 - $87,150	-110 Reduced 2.94%	3,633 $2.83 Million
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $45,691 - $53,864	-87 Reduced 2.27%	3,743 $2.18 Million
Q3 2023 Oct 12, 2023	SELL	$434.7 - $599.3 $26,082 - $35,958	-60 Reduced 1.54%	3,830 $2.06 Million
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $19,880 - $23,348	-64 Reduced 1.62%	3,890 $1.34 Million
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $16,077 - $18,733	50 Added 1.28%	3,954 $1.45 Million
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $34,005 - $39,926	-122 Reduced 3.03%	3,904 $1.27 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $26,519 - $32,957	-113 Reduced 2.73%	4,026 $1.15 Million
Q4 2021 Jan 24, 2022	SELL	$224.85 - $279.04 $33,727 - $41,856	-150 Reduced 3.5%	4,139 $1.14 Million
Q3 2021 Oct 27, 2021	BUY	$221.6 - $272.71 $178,166 - $219,258	804 Added 23.07%	4,289 $991,000
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $48,026 - $62,121	266 Added 8.26%	3,485 $800,000
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $16,432 - $21,272	-100 Reduced 3.01%	3,219 $601,000
Q4 2020 Jan 26, 2021	SELL	$130.46 - $172.63 $27,918 - $36,942	-214 Reduced 6.06%	3,319 $560,000
Q3 2020 Oct 16, 2020	BUY	$146.22 - $169.13 $4,094 - $4,735	28 Added 0.8%	3,533 $523,000
Q1 2020 Apr 20, 2020	BUY	$119.05 - $147.35 $115,716 - $143,224	972 Added 38.37%	3,505 $486,000
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $85,536 - $105,944	-800 Reduced 24.0%	2,533 $333,000
Q3 2019 Oct 23, 2019	BUY	$106.79 - $116.16 $1,067 - $1,161	10 Added 0.3%	3,333 $373,000
Q2 2019 Jul 22, 2019	SELL	$110.79 - $129.32 $2,769 - $3,233	-25 Reduced 0.75%	3,323 $368,000
Q1 2019 Apr 24, 2019	BUY	$111.31 - $131.02 $91,830 - $108,091	825 Added 32.7%	3,348 $434,000
Q4 2018 Jan 23, 2019	SELL	$105.9 - $118.64 $84,720 - $94,912	-800 Reduced 24.07%	2,523 $292,000
Q3 2018 Oct 22, 2018	BUY	$85.86 - $107.31 $68,688 - $85,848	800 Added 31.71%	3,323 $357,000
Q2 2018 Jul 24, 2018	SELL	$75.7 - $86.88 $37,850 - $43,440	-500 Reduced 16.54%	2,523 $215,000
Q1 2018 Apr 23, 2018	SELL	$74.21 - $87.6 $77,920 - $91,980	-1,050 Reduced 25.78%	3,023 $234,000
Q3 2017 Oct 11, 2017	BUY	$77.07 - $85.54 $313,906 - $348,404	4,073	4,073 $348,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.

Account

Clean Yield Group Eli Lilly & CO Transaction History